Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLONAZEPAM Cause Suspected product quality issue? 29 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Suspected product quality issue have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.1% of all adverse event reports for CLONAZEPAM.

29
Reports of Suspected product quality issue with CLONAZEPAM
0.1%
of all CLONAZEPAM reports
0
Deaths
1
Hospitalizations

How Dangerous Is Suspected product quality issue From CLONAZEPAM?

Of the 29 reports, 1 (3.4%) required hospitalization, and 2 (6.9%) were considered life-threatening.

Is Suspected product quality issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 29 reports have been filed with the FAERS database.

What Other Side Effects Does CLONAZEPAM Cause?

Drug ineffective (5,088) Toxicity to various agents (4,028) Completed suicide (3,320) Drug abuse (3,287) Off label use (2,590) Anxiety (2,376) Somnolence (2,260) Dyspnoea (1,987) Depression (1,838) Insomnia (1,836)

What Other Drugs Cause Suspected product quality issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (64) LEVOTHYROXINE (37) HUMAN IMMUNOGLOBULIN G (32) ESTRADIOL (30) ONABOTULINUMTOXINA (30) SODIUM (30) AFLIBERCEPT (27) INSULIN GLARGINE (27) IOPROMIDE (25) PROPOFOL (25)

Which CLONAZEPAM Alternatives Have Lower Suspected product quality issue Risk?

CLONAZEPAM vs CLONIDINE CLONAZEPAM vs CLOPIDOGREL CLONAZEPAM vs CLOPIDOGREL BESILATE CLONAZEPAM vs CLOPIDOGREL BISULFATE CLONAZEPAM vs CLORAZEPATE

Related Pages

CLONAZEPAM Full Profile All Suspected product quality issue Reports All Drugs Causing Suspected product quality issue CLONAZEPAM Demographics